Magnetic Resonance Imaging in Screening of Breast Cancer

被引：39

作者：

Gao, Yiming ^{[1
]}

Reig, Beatriu ^{[1
]}

Heacock, Laura ^{[1
]}

Bennett, Debbie L. ^{[2
]}

Heller, Samantha L. ^{[1
]}

Moy, Linda ^{[1
,3
,4
]}

机构：

[1] NYU, Dept Radiol, Sch Med, 160 East 34th St, New York, NY 10016 USA

[2] Washington Univ, Dept Radiol, Sch Med, 510 S Kingshighway,Box 8131, St Louis, MO 63110 USA

[3] NYU, Dept Radiol, Ctr Biomed Imaging, 660 First Ave, New York, NY 10016 USA

[4] NYU, Dept Radiol, Ctr Adv Imaging Innovat & Res, 660 First Ave, New York, NY 10016 USA

来源：

RADIOLOGIC CLINICS OF NORTH AMERICA | 2021年 / 59卷 / 01期

关键词：

Magnetic resonance imaging; Breaeast cancer screening; Abeviated MR imaging; High-risk screening; Supplemental screening; CARCINOMA IN-SITU; HIGH-RISK; ATYPICAL HYPERPLASIA; COST-EFFECTIVENESS; CHEST RADIATION; BRCA2; MUTATION; AVERAGE RISK; DIGITAL MAMMOGRAPHY; CHILDHOOD-CANCER; FAMILIAL RISK;

D O I：

10.1016/j.rcl.2020.09.004

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

MR imaging has a clear modality-based advantage compared with mammography and sonography in early breast cancer detection, and its role in screening is evolving. There is strong evidence to support MR imaging screening in high-risk women, and growing interest and varying levels of evidence for MR imaging screening in moderate-risk women. Among those screened with MR imaging, mammography offers a small incremental cancer yield, and ultrasonography is not additive. Although MR imaging screening in the average-risk population has the potential to improve detection of more relevant disease and minimize overdiagnosis, MR imaging in its current form would not be cost-effective. Abbreviated techniques have streamlined MR imaging to improve the feasibility of wider use. However, more robust data are needed to further consolidate and refine the role of MR imaging in breast cancer screening.

引用

页码：85 / 98

页数：14

共 93 条

[31] Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer [J].

Griebsch, I. ;

Brown, J. ;

Boggis, C. ;

Dixon, A. ;

Dixon, M. ;

Easton, D. ;

Eeles, R. ;

Evans, D. G. ;

Gilbert, F. J. ;

Hawnaur, J. ;

Kessar, P. ;

Lakhani, S. R. ;

Moss, S. M. ;

Nerurkar, A. ;

Padhani, A. R. ;

Pointon, L. J. ;

Potterton, J. ;

Thompson, D. ;

Turnbull, L. W. ;

Walker, L. G. ;

Warren, R. ;

Leach, M. O. .

BRITISH JOURNAL OF CANCER, 2006, 95 (07) :801-810

[32] Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers [J].

Guindalini, Rodrigo Santa Cruz ;

Zheng, Yonglan ;

Abe, Hiroyuki ;

Whitaker, Kristen ;

Yoshimatsu, Toshio F. ;

Walsh, Tom ;

Schacht, David ;

Kulkarni, Kirti ;

Sheth, Deepa ;

Verp, Marion S. ;

Bradbury, Angela R. ;

Churpek, Jane ;

Obeid, Elias ;

Mueller, Jeffrey ;

Khramtsova, Galina ;

Liu, Fang ;

Raoul, Akila ;

Cao, Hongyuan ;

Romero, Iris L. ;

Hong, Susan ;

Livingston, Robert ;

Jaskowiak, Nora ;

Wang, Xiaoming ;

Debiasi, Marcio ;

Pritchard, Colin C. ;

King, Mary-Claire ;

Karczmar, Gregory ;

Newstead, Gillian M. ;

Huo, Dezheng ;

Olopade, Olufunmilayo I. .

CLINICAL CANCER RESEARCH, 2019, 25 (06) :1786-1794

[33] Atypical Hyperplasia of the Breast - Risk Assessment and Management Options [J].

Hartmann, Lynn C. ;

Degnim, Amy C. ;

Santen, Richard J. ;

Dupont, William D. ;

Ghosh, Karthik .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (01) :78-89

[34] Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study [J].

Hartmann, Lynn C. ;

Radisky, Derek C. ;

Frost, Marlene H. ;

Santen, Richard J. ;

Vierkant, Robert A. ;

Benetti, Lorelle L. ;

Tarabishy, Yaman ;

Ghosh, Karthik ;

Visscher, Daniel W. ;

Degnim, Amy C. .

CANCER PREVENTION RESEARCH, 2014, 7 (02) :211-217

[35] The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening [J].

Houssami, Nehmat ;

Hunter, Kylie .

NPJ BREAST CANCER, 2017, 3

[36] Overdiagnosis of breast cancer in population screening: does it make breast screening worthless? [J].

Houssami, Nehmat .

CANCER BIOLOGY & MEDICINE, 2017, 14 (01) :1-8

[37] Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast [J].

Houssami, Nehmat ;

Abraham, Linn A. ;

Onega, Tracy ;

Collins, Laura C. ;

Sprague, Brian L. ;

Hill, Deirdre A. ;

Miglioretti, Diana L. .

BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) :765-773

[38] Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk [J].

King, Tari A. ;

Pilewskie, Melissa ;

Muhsen, Shirin ;

Patil, Sujata ;

Mautner, Starr K. ;

Park, Anna ;

Oskar, Sabine ;

Guerini-Rocco, Elena ;

Boafo, Camilla ;

Gooch, Jessica C. ;

De Brot, Marina ;

Reis-Filho, Jorge S. ;

Morrogh, Mary ;

Andrade, Victor P. ;

Sakr, Rita A. ;

Morrow, Monica .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) :3945-+

[39] Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition [J].

Kriege, Mieke ;

Brekelmans, Cecile T. M. ;

Boetes, Carla ;

Muller, Sara H. ;

Zonderland, Harmine M. ;

Obdeijn, Inge Marie ;

Manoliu, Radu A. ;

Kok, Theo ;

Rutgers, Emiel J. T. ;

de Koning, Harry J. ;

Klijn, Jan G. M. .

CANCER, 2006, 106 (11) :2318-2326

[40] Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial [J].

Kuhl, Christiane ;

Weigel, Stefanie ;

Schrading, Simone ;

Arand, Birke ;

Bieling, Heribert ;

Koenig, Roy ;

Tombach, Bernd ;

Leutner, Claudia ;

Rieber-Brambs, Andrea ;

Nordhoff, Dennis ;

Heindel, Walter ;

Reiser, Maximilian ;

Schild, Hans H. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1450-1457

← 1 2 3 4 5 6 7 8 9 10 →